Cargando…

Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning

PURPOSE: The current study aimed to evaluate the efficiency of dynamic contrast-enhanced (DCE) MRI visual features in classifying benign liver nodules and hepatocellular carcinoma (HCC) using a machine learning model. METHODS: 115 LI-RADS3, 137 LI-RADS4, and 140 LI-RADS5 nodules were included (392 n...

Descripción completa

Detalles Bibliográficos
Autores principales: Fotouhi, Maryam, Samadi Khoshe Mehr, Fardin, Delazar, Sina, Shahidi, Ramin, Setayeshpour, Babak, Toosi, Mohssen Nassiri, Arian, Arvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641154/
https://www.ncbi.nlm.nih.gov/pubmed/37964787
http://dx.doi.org/10.1016/j.ejro.2023.100535
_version_ 1785146712497586176
author Fotouhi, Maryam
Samadi Khoshe Mehr, Fardin
Delazar, Sina
Shahidi, Ramin
Setayeshpour, Babak
Toosi, Mohssen Nassiri
Arian, Arvin
author_facet Fotouhi, Maryam
Samadi Khoshe Mehr, Fardin
Delazar, Sina
Shahidi, Ramin
Setayeshpour, Babak
Toosi, Mohssen Nassiri
Arian, Arvin
author_sort Fotouhi, Maryam
collection PubMed
description PURPOSE: The current study aimed to evaluate the efficiency of dynamic contrast-enhanced (DCE) MRI visual features in classifying benign liver nodules and hepatocellular carcinoma (HCC) using a machine learning model. METHODS: 115 LI-RADS3, 137 LI-RADS4, and 140 LI-RADS5 nodules were included (392 nodules from 245 patients), which were evaluated by follow-up imaging for LR-3 and pathology results for LR-4 and LR-5 nodules. Data was collected retrospectively from 3 T and 1.5 T MRI scanners. All the lesions were categorized into 124 benign and 268 HCC lesions. Visual features included tumor size, arterial-phase hyper-enhancement (APHE), washout, lesion segment, mass/mass-like, and capsule presence. Gini-importance method extracted the most important features to prevent over-fitting. Final dataset was split into training(70%), validation(10%), and test dataset(20%). The SVM model was used to train the classifying algorithm. For model validation, 5-fold cross-validation was utilized, and the test data set was used to assess the final accuracy. The area under the curve and receiver operating characteristic curves were used to assess the performance of the classifier model. RESULTS: For test dataset, the accuracy, sensitivity, and specificity values for classifying benign and HCC lesions were 82%,84%, and 81%, respectively. APHE, washout, tumor size, and mass/mass-like features significantly differentiated benign and HCC lesions with p-value < .001. CONCLUSIONS: The developed classification model employing DCE-MRI features showed significant performance of visual features in classifying benign and HCC lesions. Our study also highlighted the significance of mass and mass-like features in addition to LI-RADS categorization. For future work, this study suggests developing a deep-learning algorithm for automatic lesion segmentation and feature assessment to reduce lesion categorization errors.
format Online
Article
Text
id pubmed-10641154
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106411542023-11-14 Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning Fotouhi, Maryam Samadi Khoshe Mehr, Fardin Delazar, Sina Shahidi, Ramin Setayeshpour, Babak Toosi, Mohssen Nassiri Arian, Arvin Eur J Radiol Open Article PURPOSE: The current study aimed to evaluate the efficiency of dynamic contrast-enhanced (DCE) MRI visual features in classifying benign liver nodules and hepatocellular carcinoma (HCC) using a machine learning model. METHODS: 115 LI-RADS3, 137 LI-RADS4, and 140 LI-RADS5 nodules were included (392 nodules from 245 patients), which were evaluated by follow-up imaging for LR-3 and pathology results for LR-4 and LR-5 nodules. Data was collected retrospectively from 3 T and 1.5 T MRI scanners. All the lesions were categorized into 124 benign and 268 HCC lesions. Visual features included tumor size, arterial-phase hyper-enhancement (APHE), washout, lesion segment, mass/mass-like, and capsule presence. Gini-importance method extracted the most important features to prevent over-fitting. Final dataset was split into training(70%), validation(10%), and test dataset(20%). The SVM model was used to train the classifying algorithm. For model validation, 5-fold cross-validation was utilized, and the test data set was used to assess the final accuracy. The area under the curve and receiver operating characteristic curves were used to assess the performance of the classifier model. RESULTS: For test dataset, the accuracy, sensitivity, and specificity values for classifying benign and HCC lesions were 82%,84%, and 81%, respectively. APHE, washout, tumor size, and mass/mass-like features significantly differentiated benign and HCC lesions with p-value < .001. CONCLUSIONS: The developed classification model employing DCE-MRI features showed significant performance of visual features in classifying benign and HCC lesions. Our study also highlighted the significance of mass and mass-like features in addition to LI-RADS categorization. For future work, this study suggests developing a deep-learning algorithm for automatic lesion segmentation and feature assessment to reduce lesion categorization errors. Elsevier 2023-10-31 /pmc/articles/PMC10641154/ /pubmed/37964787 http://dx.doi.org/10.1016/j.ejro.2023.100535 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Fotouhi, Maryam
Samadi Khoshe Mehr, Fardin
Delazar, Sina
Shahidi, Ramin
Setayeshpour, Babak
Toosi, Mohssen Nassiri
Arian, Arvin
Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning
title Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning
title_full Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning
title_fullStr Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning
title_full_unstemmed Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning
title_short Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning
title_sort assessment of li-rads efficacy in classification of hepatocellular carcinoma and benign liver nodules using dce-mri features and machine learning
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641154/
https://www.ncbi.nlm.nih.gov/pubmed/37964787
http://dx.doi.org/10.1016/j.ejro.2023.100535
work_keys_str_mv AT fotouhimaryam assessmentofliradsefficacyinclassificationofhepatocellularcarcinomaandbenignlivernodulesusingdcemrifeaturesandmachinelearning
AT samadikhoshemehrfardin assessmentofliradsefficacyinclassificationofhepatocellularcarcinomaandbenignlivernodulesusingdcemrifeaturesandmachinelearning
AT delazarsina assessmentofliradsefficacyinclassificationofhepatocellularcarcinomaandbenignlivernodulesusingdcemrifeaturesandmachinelearning
AT shahidiramin assessmentofliradsefficacyinclassificationofhepatocellularcarcinomaandbenignlivernodulesusingdcemrifeaturesandmachinelearning
AT setayeshpourbabak assessmentofliradsefficacyinclassificationofhepatocellularcarcinomaandbenignlivernodulesusingdcemrifeaturesandmachinelearning
AT toosimohssennassiri assessmentofliradsefficacyinclassificationofhepatocellularcarcinomaandbenignlivernodulesusingdcemrifeaturesandmachinelearning
AT arianarvin assessmentofliradsefficacyinclassificationofhepatocellularcarcinomaandbenignlivernodulesusingdcemrifeaturesandmachinelearning